NYSE · Healthcare
Ardent Health, Inc. (ARDT)
As-reported financials and recent SEC filings for Ardent Health, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$6.32B
Net income
$135.8M
Net margin
2.1%
Diluted EPS
$0.96
ROE
8.1%
P/E (TTM)
10.4×
Market cap
$1.39B
Debt / equity
0.6×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2024 | FY2024 |
|---|---|---|---|---|
| Revenue | $6.32B | $5.97B | $5.41B | $5.13B |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | $135.8M | $210.3M | $53.9M | $188.9M |
| Diluted EPS | $0.96 | $1.58 | $0.43 | $1.50 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →8-K2026-06-02
View on EDGAR →8-K2026-05-26
View on EDGAR →10-Q2026-05-06
View on EDGAR →8-K2026-05-05
View on EDGAR →ARS2026-04-08
View on EDGAR →DEFA14A2026-04-08
View on EDGAR →Go deeper on ARDT
Search Ardent Health, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.